Evidence map›Paper›PMID 34610937›Full record

ArticleBMJ open2021

Prevalence of disposable pod use and consumer preference for e-cigarette product characteristics among vape shop customers in Southern California: a cross-sectional study.

Artur Galimov, Adam Leventhal, Leah Meza, Jennifer B Unger, Jimi Huh, Lourdes Baezconde-Garbanati, Steven Y Sussman

Open access · goldAbstract read
In one paragraph

Article in BMJ open, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Ice Flavor-Related Discussions on Twitter: Content Analysis.Journal of medical Internet research · 2022
    Article
  10. Article
  11. Review
  12. Synthetic Cooling Agents in US-marketed E-cigarette Refill Liquids and Popular Disposable E-cigarettes: Chemical Analysis and Risk Assessment.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Artur GalimovDepartment of Population and Public Health Sciences, University of Southern California Keck School of Medicine, Los Angeles, California, USA galimov@usc.edu.ORCID 0000-0002-9718-439X
Adam LeventhalDepartment of Population and Public Health Sciences, University of Southern California Keck School of Medicine, Los Angeles, California, USA.
Leah MezaDepartment of Population and Public Health Sciences, University of Southern California Keck School of Medicine, Los Angeles, California, USA.
Jennifer B UngerDepartment of Population and Public Health Sciences, University of Southern California Keck School of Medicine, Los Angeles, California, USA.
Jimi HuhDepartment of Population and Public Health Sciences, University of Southern California Keck School of Medicine, Los Angeles, California, USA.
Lourdes Baezconde-GarbanatiDepartment of Population and Public Health Sciences, University of Southern California Keck School of Medicine, Los Angeles, California, USA.
Steven Y SussmanDepartment of Population and Public Health Sciences, University of Southern California Keck School of Medicine, Los Angeles, California, USA.
University of Southern California · US

Funding

USC Tobacco Center of Regulatory ScienceU54CA180905 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI Raina Pang · 2018 to 2026
$39.0M
Tobacco Use Treatment Research for Vulnerable PopulationsK24DA048160 · NIDA · UNIVERSITY OF SOUTHERN CALIFORNIA · PI Adam Matthew Leventhal · 2019 to 2026
$1.4M
NCI NIH HHS U54 CA180905NIDA NIH HHS K24 DA048160
6 · The paper itself

Abstract

objectivesIn February 2020, the US Food and Drug Administration issued a guidance restricting the sales and distribution of cartridge-based e-cigarettes with flavours other than tobacco and menthol. Disposable devices were exempt from this guidance. This study examined the prevalence of disposable pod use and flavour preference compared with refillable pod and other e-cigarette users among vape shop customers.

designCross-sectional study.

settingIn July 2019-March 2020, trained data collectors visited 44 vape shops in California with permission to recruit customers from shop owners.

participantsIntercept interviews with 276 customers were conducted. OUTCOMES AND PROCEDURES: Customers were grouped based on self-reported device type used most often (disposable pod, refillable pod and other e-cigarettes). Groups were compared on self-reported demographics, flavours preferred, daily e-cigarette use, preferred nicotine concentration levels and cigarette use.

resultsOf the 276 customers surveyed, 11.2% used disposable pods in the past 30 days. Among disposable pod users, fruit/candy (80.7%), mint (77.4%) and menthol (67.7%) were common preferred flavours, while tobacco flavours were less commonly preferred (19.4%). When compared with refillable pod and other non-pod e-cigarette device users, disposable pod users were younger, used higher nicotine concentration levels, were more likely to prefer mint and menthol flavours and use e-cigarettes as their first product, while less likely to ever use cigarettes and use e-cigarettes daily. DISCUSSION: Despite using higher nicotine levels and preferred menthol/mint flavours more often than users of other devices, disposable pod users reported lower prevalence of lifetime smoking and daily vaping and were younger. Given the current findings, regulations addressing non-tobacco flavours and nicotine concentration in disposable pod devices merit consideration in efforts to reduce vaping in younger adult never smokers.

Indexed as

Electronic Nicotine Delivery SystemsTobacco ProductsVapingAdultCaliforniaConsumer BehaviorCross-Sectional StudiesHumansPrevalencehealth policypublic healthsubstance misuse

Identifiers

PMID34610937
PMCPMC8493914
OpenAlexW3202846900

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.